Skip to main content

Peer Review reports

From: Co-mutations of TP53 and KRAS serve as potential biomarkers for immune checkpoint blockade in squamous-cell non-small cell lung cancer: a case report

Original Submission
24 May 2019 Submitted Original manuscript
25 Jun 2019 Reviewed Reviewer Report - Qian Li
15 Jul 2019 Reviewed Reviewer Report - Jiehui Deng
29 Jul 2019 Author responded Author comments - Cheng Fang
Resubmission - Version 2
29 Jul 2019 Submitted Manuscript version 2
24 Aug 2019 Reviewed Reviewer Report - Qian Li
27 Aug 2019 Reviewed Reviewer Report - Jiehui Deng
31 Aug 2019 Author responded Author comments - Cheng Fang
Resubmission - Version 3
31 Aug 2019 Submitted Manuscript version 3
14 Sep 2019 Author responded Author comments - Cheng Fang
Resubmission - Version 4
14 Sep 2019 Submitted Manuscript version 4
Publishing
24 Sep 2019 Editorially accepted
16 Oct 2019 Article published 10.1186/s12920-019-0592-6

You can find further information about peer review here.

Back to article page